DIUXF (Diaceutics) Buildings And Improvements: $3.03 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DIUXF Diaceutics PLC DIUXF
85 GF Score
Price $2.00
GF Value $2.71
! 1 Warning Sign
View Full Analysis

What is Diaceutics Buildings And Improvements?

Diaceutics DIUXF 85 Buildings And Improvements is $3.03 Mil as of Dec. 2025. GuruFocus rates DIUXF with a GF Score™ of 85/100 and a GF Value™ of $2.71. The stock has 1 warning sign investors should review.

Diaceutics's quarterly buildings and improvements declined from Dec. 2024 ($2.62 Mil) to Jun. 2025 ($0.72 Mil) but then increased from Jun. 2025 ($0.72 Mil) to Dec. 2025 ($3.03 Mil).

Diaceutics's annual buildings and improvements declined from Dec. 2023 ($2.62 Mil) to Dec. 2024 ($2.62 Mil) but then increased from Dec. 2024 ($2.62 Mil) to Dec. 2025 ($3.03 Mil).

Diaceutics Buildings And Improvements Historical Data

* Premium members only.

The historical data trend for Diaceutics's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diaceutics Buildings And Improvements Chart

Diaceutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buildings And Improvements
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.58 2.52 2.62 2.62 3.03

Diaceutics Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Buildings And Improvements Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.62 0.68 2.62 0.72 3.03
DIUXF
85GF Score
Diaceutics PLC DIUXF
Buildings And Improvements is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Diaceutics Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction.  Broker and architect fees, permits, etc. can be covered within this category.  Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized.  Improvements are commonly recorded at acquisition cost.  Building improvement examples include roofing, remodeling, replacements, etc.

What does a Buildings And Improvements of $3.03 Mil mean?
Diaceutics (DIUXF) has a Buildings And Improvements of $3.03 Mil as of Dec. 2025. Buildings and improvements is the total value of a company's buildings and improvements to them. View historical data on Diaceutics and its competitors.
Is Diaceutics' Buildings And Improvements too high?
Diaceutics' current Buildings And Improvements is $3.03 Mil. Overall, Diaceutics has a GF Score™ of 85/100, reflecting its overall financial health beyond just this single metric.
How does Diaceutics' Buildings And Improvements compare to VEEV and BTSG?
Diaceutics' Buildings And Improvements of $3.03 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buildings And Improvements for a Healthcare Providers & Services company?
A good Buildings And Improvements depends on the Healthcare Providers & Services industry context. However, Buildings And Improvements should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buildings And Improvements mean?
A high Buildings And Improvements can signal that a stock is expensive relative to its fundamentals. Buildings and improvements is the total value of a company's buildings and improvements to them. View historical data on Diaceutics and its competitors. Diaceutics's current Buildings And Improvements is $3.03 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diaceutics stock overvalued right now?
Diaceutics (DIUXF) has a current Buildings And Improvements of $3.03 Mil. The stock's GF Value™ is $2.71, compared to a current price of $2.00 — trading 26.2% below its estimated fair value. The current Buildings And Improvements is $3.03 Mil. Diaceutics' overall GF Score™ is 85/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buildings And Improvements calculated?
Buildings And Improvements is calculated from a company's financial statements. For Diaceutics (DIUXF), the current Buildings And Improvements is $3.03 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Diaceutics (DIUXF) Overvalued in 2026?

Based on GuruFocus' analysis, Diaceutics stock appears to be undervalued. The current stock price of $2.00 is trading 26.2% below its estimated GF Value™ of $2.71.

Key valuation signals for DIUXF:

  • Buildings And Improvements: $3.03 Mil
  • GF Value™: $2.71 vs. price of $2.00 (26.2% below fair value)
  • GF Score™: 85/100 with 1 warning sign

No single metric tells the full story. See the DIUXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Diaceutics Business Description

Other Exchanges DXRX:UK7DC:Germany
Address Dataworks at Kings Hall Health & Wellbeing Park, First Floor, Building Two, County Antrim, Belfast, GBR, BT9 6GW
Diaceutics PLC is a data analytics and implementation services company that services the pharmaceutical industry. It provides integrated commercialization solutions that help biopharma companies maximize patient access, accelerate uptake, and improve the lifetime value of their therapies. The group's services span the full commercial lifecycle, from pre-launch ideas through to mature brand optimization, delivered through an integrated combination of data, technology, and expertise. Its DXRX Data Solutions include DXRX Signal, DXRX Physician Segmentation, DXRX Lab Segmentation, and DXRX Disease Testing Rate Tracker. Geographical market by customer location in the UK, North America, Europe, Asia, and the rest of the world.
85GF Score

Get the complete analysis for DIUXF

Buildings And Improvements is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.00
Price
$2.71
GF Value